The agency is proposing a requirement that companies submit data when self-affirming an additive is safe for consumption.

The US FDA has issued new guidance on ways to expand development of non-opioid treatment options for chronic pain.

The FDA is mandating labeling changes for opioid pain medications to highlight the risks associated with their prolonged use. In May, members of a public advisory committee examined data linking ...

SAN FRANCISCO (KGO) -- The FDA granted full approval of the Pfizer COVID-19 vaccine Monday for people 16 and older, paving the way for additional vaccine mandates. Experts wonder will California be ...

The U.S. Food and Drug Administration (FDA) has announced a significant update to the labeling of all extended-release medications used to treat Attention-Deficit ...

Florida Surgeon General Joseph Ladapo on Sunday acknowledged his team had not conducted any studies on the effects of ...

AUSTIN, Texas -- Gov. Greg Abbott on Wednesday announced an executive order banning COVID-19 vaccine mandates regardless of a vaccine's approval status with the U.S. Food and Drug Administration. He ...

Vinay Prasad has regained his role as the U.S. Food and Drug Administration's chief medical and scientific officer, according ...

The Democratic governors of California, Oregon and Washington said Wednesday they are forming an alliance to coordinate ...